Skip to content

Acute effects of photobiomodulation on respiratory variables and functional capacity in smokers and ex-smokers

Acute effects of photobiomodulation on respiratory variables and functional capacity in smokers and ex-smokers: randomized clinical trial, triple-blind and controlled placebo

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7nj9w4
Enrollment
Unknown
Registered
2020-07-27
Start date
2020-01-14
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Interventions

Photobiomodulation by low-intensity LEDs was performed using a non-commercial light-emitting array (cluster) of 69 LEDs. This device contains 35 LEDs that emit light in the red range (630 ± 10 nm
10 mW
0.2 cm2) and 34 LEDs in the infrared range (830 ± 20 nm
0.2 cm2) arranged interchangeably in a circular emitting area of ??40 cm2. The device was in contact with the skin at 90 ° and with light pressure, for 90 seconds at each point. The photobiomodulation
Device
Radiation
E02.774

Sponsors

Universidade Brasil
Lead Sponsor
Universidade Brasil
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: For study 1 volunteers aged over 18 years will be included; smokers aged 1-10 years and smokers aged 11-20 years. For study 2 volunteers aged over 18 were included; ex-smokers for a period of at least 12 months. All volunteers must be clinically stable; do not show dyspnea symptoms on small and medium efforts.

Exclusion criteria

Exclusion criteria: Alcoholic volunteers who have a cardiac pacemaker implant, coexisting neurological disease and have presented any lung disease diagnosed, or use of corticosteroids in the last 4 weeks. Volunteers who practice regular physical exercise, defined as participation in pulmonary rehabilitation programs or structured physical training (3 times per week) in the last three months.

Design outcomes

Primary

MeasureTime frame
Evaluate the pulmonary function index, using the forced vital capacity spirometry (FVC) method expressed as a predicted percentage (%). We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.;Evaluate the pulmonary function index, using the forced expiratory volume spirometry method in the first second (FEV1) expressed as a predicted percentage (%). We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.;Evaluate the pulmonary function index, using the spirometric maneuver method Ratio between forced expiratory volume in the first second (FEV1) and forced vital capacity (FVC), called the "Tiffeneau index" expressed in predicted percentage (%). We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.;To evaluate the pulmonary function index, using the method of maximum voluntary ventilation (VVM) spirometric maneuver expressed in liters per minute (l / min). We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.

Secondary

MeasureTime frame
Assess thoracoabdominal mobility, using the cirtometry method, expressed in centimeters (cm). We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.;Assess the functional capacity of the volunteers using the 6-minute walk test method, expressed in meters (m). We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.;Evaluate the hemodynamic heart rate variable, expressed in beats per minute (bpm) using the 6-minute walk test. We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.;Using the 6-minute walk test, evaluate the hemodynamic blood pressure variable, expressed in millimeters of mercury (mmHg). We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.;Evaluate by means of the 6-minute walk test the hemodynamic variable peripheral capillary oxygen saturation, expressed as a percentage (%). We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify the influence of photobiomodulation on them.;Evaluate by means of the 6-minute walk test the variable Borg's perceived exertion scale, expressed in a numerical scale from 0 to 10. We will observe the evaluation and characterization of the behavior of the cardiorespiratory responses studied in the volunteers selected for the research, allowing to clarify t

Countries

Brazil

Contacts

Public ContactCleber;Thaline Ferraresi;Castrillon Macedo

Universidade Brasil;Usina Barralcool

cleber.ferraresi@gmail.com;thalinecastrillon@gmail.com+55-011-20700098;+55-065-33616600

Outcome results

None listed

Source: REBEC (via WHO ICTRP)